Young people with private health insurance lived longer than those on Medicaid or without insurance. Depending on the cancer, this survival advantage ranged from a modest 8% lower risk of death for ...
After 5 years of follow-up, mRNA-based COVID-19 vaccination was independently associated with improved long-term survival in patients with solid tumors who survived COVID-19 hospitalization.